Surveys

As part of an EANM initiative, this survey aims at collecting a high-level snapshot of current practice in 177Lu-based targeted radionuclide therapy (PSMA & SSTR), including post-therapy imaging and dosimetry.

The survey also explores the practical capacity of centres to perform absorbed dose verification in a small patient cohort as part of routine clinical workflows.

This is Stage 1 of a two-stage project designed to ensure future discussions and potential guidance reflect real-world clinical practice across Europe.

⏰ Please participate before April 10, and share it with colleagues! It will take you only 5 minutes to complete.

Participate now Preview